# A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection Therapy

> **NCT02623452** · PHASE1 · WITHDRAWN · sponsor: **Eli Lilly and Company**

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Insulin Lispro

## Key facts

- **NCT ID:** NCT02623452
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-01
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Change in clinical strategy
- **Last updated:** 2017-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02623452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02623452, "A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02623452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*